hypocholesterolemics (Pierre Fabre)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namehypocholesterolemics (Pierre Fabre)
Drug Alias NameF-12246F-12196
ClassificationSmall molecules
Mechanisms of ActionSqualene monooxygenase inhibitorsantioxidant
TargetsSqualene monooxygenase
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPierre Fabre Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPierre Fabre Ltd
Active IndicationsN/A
Inactive IndicationsHypercholesterolemia

Other Information

ATC CodeN/A
Related LinksN/A